iTechGuides is reader-supported. When you buy through links on our site, we may earn an affiliate commission. As an Amazon Associate I earn from qualifying purchases. Learn more
The reported 13.67% rise to ₪1,962.32 cannot be verified from the available source data: its provider, date, listing and currency-conversion method are not established. A separate TipRanks snapshot reviewed October 4, 2026, gives U.S.-listed Lineage Cell Therapeutics (LCTX) an average 12-month target of $6.25 from five analysts—not a shekel-denominated target.
What the available LCTX analyst data says
TipRanks’ forecast page for Lineage Cell Therapeutics, Inc. (NASDAQ: LCTX) displayed a $6.25 average 12-month price target on October 4, 2026. The page attributed the average to five analysts and showed a low of $3 and a high of $9. These are U.S.-dollar figures for the U.S.-listed security, not evidence for the headline’s ₪1,962.32 figure. TipRanks LCTX forecast
The page’s visible individual entries included four dated target amounts. Craig-Hallum was listed as Buy, but no target amount was displayed for it.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →| Analyst or firm | Target | Date shown |
|---|---|---|
| B. Riley Securities | $4 | September 24, 2026 |
| Maxim Group | $3 | August 11, 2026 |
| H.C. Wainwright | $9 | August 7, 2026 |
| Canaccord Genuity | $9 | August 6, 2026 |
| Craig-Hallum | Target not displayed | Date not displayed |
The dates and targets are the entries visible on the TipRanks page reviewed October 4, 2026. The page is a changing secondary aggregator, so these figures should be treated as a snapshot rather than independently confirmed analyst reports.
#1 Best Overall
Why the stated shekel target and 13.67% increase are unconfirmed
The available data does not identify the source that reported ₪1,962.32 or the earlier value from which a 13.67% increase was calculated. It also does not establish the observation date, which listing the figure concerns, or whether and how a currency conversion was applied. Consequently, the reported amount and percentage cannot be checked against the TipRanks U.S.-dollar consensus.
TipRanks has a separate page for German-listed BT3, but its page snapshots are temporally inconsistent and do not corroborate the shekel amount. TipRanks BT3 forecast
Rank #2
- Comes with secure packaging
- Easy to read text
- It can be a gift option
How to interpret analyst price targets
A consensus target summarizes estimates; it is not a promised future share price, a guaranteed return, or a recommendation to buy or sell. The $3-to-$9 spread on the reviewed LCTX page shows that the displayed estimates differ materially. The average alone does not show why analysts chose their targets or how likely any target is to be reached.
To assess a reported target change, check that both figures refer to the same security and listing, use the same currency and provider, and compare like-for-like dates. A percentage change is meaningful only when the starting figure and calculation can be identified. The reviewed TipRanks figures do not establish those details for the headline claim.
Quick Recap
Best Value
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
